SBIR/STTR Research Award

Reduction of HAART-Induced Side Effects in HIV Patients

Award identifier 5b47d47f4340afa531af7f72cf0aff7752a7e7b7b363e7d5ec429a3dd28ced43Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$101,213

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
KELLIHER AND ASSOCIATES
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

We intend to provide highly specialized clinical consultation services to providers and patients in order to increase the health and well being of people infected with HIV/AIDS. The Highly Active Anti Retroviral Therapy (HAART) can cause severe side effects, often making people feel worse than from the disease and leading to significant changes in body composition and metabolism This often leads to a change in therapy or a "drug holiday" where medications are stopped for a short period. In this project we will further develop protocols, incorporating a multidisciplinary team of a nutritionist, pharmacist and exercise physiologist, to reduce the side effects of antiviral therapies. Our protocols will seek to markedly reduce the lipodystrophy found in 83% of patients on protease inhibitors, the hyperlipidemia found in 74% and the hyperglycemia in 16%. Using a two cohort design with 15 patients in treatment cohort and 25 in the control, we will incorporate dietary and nutrient supplementation combined with pharmacy drug adherence strategies and a program of resistance exercise for 12 weeks to evaluate the effects of these strategies on biochemical values, physical assessment, side effect incidence and quality of life. The control group will continue to receive the community standard of care throughout the 12 weeks. The results of our study will provide caregivers and patients with specific strategies to reduce the side effects from antiviral therapies and increase the time that patients can continue on effective virus suppressing therapies. PROPOSED COMMERCIAL APPLICATIONS: HAART dramatically increases the life expectancy for the nearly half million Americans infected with HIV, but side effects are very common. Through protocols involving diet, pharmacy counseling and exercise we aim to dramatically reduce the side effects of HAART. We aim to develop teams in the cities with the highest prevalence of HIV infection. These teams will expand their reach through Internet assisted tools to deliver care to a large number of patients.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.